M Ventures is a strategic, corporate venture capital fund investing in Biotechnology - with verticals in Healthcare and Life Science tools - and Technology - with verticals in Semiconductors and Displays as well as Sustainable Manufacture.

M Ventures 

🚨 𝐋𝐚𝐬𝐭 𝐜𝐡𝐚𝐧𝐜𝐞 𝐭𝐨 𝐚𝐩𝐩𝐥𝐲 𝐟𝐨𝐫 𝐒𝐭𝐚𝐫𝐭𝐮𝐩𝐬 𝐟𝐨𝐫 𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐥𝐞 𝐒𝐞𝐦𝐢𝐜𝐨𝐧𝐝𝐮𝐜𝐭𝐨𝐫𝐬 (𝐒𝟑) 🚨

Are you a startup with a game-changing innovation for the semiconductor industry? Do you want to learn from the best corporate venture capital firms and experts in the field? 
If yes, then you need to apply for Startups for Sustainable Semiconductors (S3), a program backed by M Ventures along with more than ten other CVCs from the semiconductor ecosystem.
S3 is looking for startups that can tackle the challenges of water, materials, energy, and emissions efficiency in the semiconductor industry. The selected startups will get access to mentorship, feedback, and networking opportunities from the S3 partners and mentors. 
𝗣𝗹𝘂𝘀, 𝘆𝗼𝘂 𝗺𝗶𝗴𝗵𝘁 𝗮𝗹𝘀𝗼 𝗴𝗲𝘁 𝗮 𝗰𝗵𝗮𝗻𝗰𝗲 𝘁𝗼 𝗽𝗶𝘁𝗰𝗵 𝘆𝗼𝘂𝗿 𝘀𝘁𝗮𝗿𝘁𝘂𝗽 𝘁𝗼 𝘁𝗵𝗲 𝗦𝟯 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀 𝗳𝗼𝗿 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁.💰

The application deadline is 𝗠𝗮𝗿𝗰𝗵 𝟭𝘀𝘁, so don’t miss this opportunity to join the S3 program and boost your sustainable impact. 💯

To find out more about S3 and how to apply, visit https://lnkd.in/eYbjNwXn and we will look forward to the opportunity to meet you at Semicon West in July!

To read a blog post by some of the mentors of S3, Jennifer Ard, CFA, Alexandra Farmer, Tobias Egle, and Sarah Luppino, Ph.D., click here: https://lnkd.in/eMfrCTmg

#Semiconductor #Startups #Sustainability #startups4sustainability #CVC


M Ventures  is happy to support the Semi Sustainability Initiative! 
Are you working on, or have you heard of new ideas, products or services for sustainability which need backers? Can the idea be applied to the semiconductor ecosystem? The window for applying to the mentoring program and pitching at the upcoming events, is open through February 28. Learn more at https://lnkd.in/gHVgBubz

#sustainable_semiconductors #sustainabilitySEMI #startups4sustainability

3 days, 40.000 steps, and about 35 kilometers later, I’m heading back to Germany after attending CES – I could not have asked for a more exciting and energizing way to start the year!
 
This week, we’ve had important conversations with valued customers and partners about our joint efforts to simultaneously leverage and advance AI and Machine Learning in key areas like R&D and manufacturing.
 
I was proud to see Laura Matz and Katherine Dei Cas represent the best of our company at such a prominent event with their contributions to the conversations about AI and women’s entrepreneurship. 
 
Through M Ventures, our company’s corporate venture capital fund, we hosted startups at our booth and learned about their exciting ideas to shape the future of Electronics.
 
Throughout the week, we also connected with attendees and shared how our material intelligence can be found inside almost every digital device. We broke down what it truly takes to unlock next-level computing and next-generation chips.
 
As I head home, I want to send a sincere thank you to my entire Electronics team for making our participation at this year’s CES a complete success. Your dedication and hard work never cease to amaze me. Let's carry this momentum into the upcoming year, staying energized and ready for even greater achievements together in 2024!

#CES2024 #AdvancingDigitalLiving

M Ventures  portfolio company Calypso, a Merck spin-out, enters into agreement to be acquired by Novartis!

https://lnkd.in/eQ2uKmRe

Domain Not Resolving

DMARC

Microsoft Azure DNS

403 Error

Proofpoint

Incapsula

Adobe Enterprise Cloud

Imperva Bot Detection and Mitigation

PowerDMARC

Investment Director, Technology Investments

Daniel Franke

Managing Director

Hakan Goker

Owen Lozman

Investment Associate

Bauke Anninga

Co-Founder & General Partner

Charles King

Fellow

Charlotte Kremers

Engineering

Christian Uhrich

Investment Associate | Biotechnology & Life Sciences

Jon Nash

Office Assistant

Leonie Willemse

Co-Founder, Co-Owner

Maegan Garee

Vice President and Head of Performance Materials Fund

Javier Rodriguez

Tony Chang

Associate

Marco Rau

Head of Legal Strategy and Transformation

Cheryl Zimberlin

Keno Gutierrez

Investment Director

Team assistant

Friedrich Rippmann

Director, Global Computational Chemistry and Biology

SIMULATE's mission is to upgrade the world to a positive food system.

Ambrx is a clinical-stage biopharmaceutical company using expanded genetic code technology for next-gen therapies and immune modulation.

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

Progyny is a fertility benefits management company.

Calypso Biotech's vision is to give new hope to patients suffering from severe gastro-intestinal diseases.

Akili is a digital therapeutics company that offers Innovative video game-based therapies for neurological and psychiatric conditions.

Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.

F-Star Therapeutics is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.

Venture Capital Investors with Investments in Copenhagen, Hovedstaden

Investors Active in Switzerland

Seed Stage Investors with Investments in Sachsen

Venture Capital Investors with Investments in Singapore

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Amsterdam

Noord-Holland

The Netherlands

Europe

M Ventures

IonKraft Secures €3.5 Million to Revolutionize Sustainable Packaging

IonKraft Raises €3.5M in Funding

IonKraft raises €3.5M funding for plasma-based tech bringing circular economy in plastic packaging

Last week recap: More than 95 tech funding deals worth over €1.2B

Aachen-based IonKraft secures €3.5 million to drive circular economy in packaging

Germany-based IonKraft secures €3.5M to make packaging more circular: Know more

IonKraft secures €3.5M equity funding to fuel circular economy in packaging.

United States

North America

United Kingdom

Philippines

Asia

Thailand

Bangladesh

Rock Health is a venture capital firm that focuses on investing in digital health startups.

Rock Health

Healthy Ventures is a venture capital firm specializing in healthcare and wellness technology investments.

Healthy Ventures

Virtue VC is a venture capital firm that invests in early-stage healthcare and life sciences companies.

Virtue VC

Lerer Hippeau is a venture capital firm that invests in technology and healthcare startups.

Lerer Hippeau

Flare Capital is a venture capital firm that specializes in healthcare technology investments.

Flare Capital

Susa Ventures is a venture capital firm that invests in technology and healthcare companies.

Susa Ventures

Lux Capital is a venture capital firm that invests in technology and healthcare companies.

Lux Capital

General Catalyst is a venture capital firm that invests in technology and healthcare startups.

General Catalyst

Kamylon Capital is a venture capital firm that invests in various industries, including healthcare technology.

Kamylon Capital

OrbiMed is a leading healthcare investment firm that invests in innovative healthcare companies.

OrbiMed

Felicis Ventures is a venture capital firm that invests in healthcare and technology companies.

Felicis Ventures

New Enterprise Associates is a global venture capital firm that invests in various sectors, including healthcare.

New Enterprise Associates

BoxGroup is a venture capital firm that invests in technology and healthcare startups.

BoxGroup

SV Health Investors is a venture capital firm that focuses on investing in healthcare and life sciences companies.

SV Health Investors

M-Ventures is a venture capital firm that invests in innovative startups, with a focus on technology and healthcare sectors. They provide funding, mentorship, and strategic support to early-stage companies, helping them to scale and bring new products to market.

news impact assignment basic	general
public peers	general	May 10, 2024 7:35 AM	d166f8bc
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:09 AM	704bbd82
crunchbase profile	general	Nov 25, 2024 11:38 AM	590a7d41
li profile	general	May 10, 2024 7:35 AM	19a270a0
translate crunchbase fundingrounds	general	Nov 25, 2024 2:10 PM	96192148
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:M-VENTURES

M-Ventures